Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan-based Therapy vs Standard Regimen for H. pylori
NCT05614934Phase 4Completed
- Sponsor
- Alexandria University
- Start
- Jun 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vonoprazan in Helicobacter pylori infection, sponsored by Alexandria University. Started Jun 2022; status: completed.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05614934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05614934.